Exact Sciences
EXAS
#1179
Rank
ยฃ14.20 B
Marketcap
ยฃ74.78
Share price
0.04%
Change (1 day)
64.00%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -ยฃ0.78 Billion

According to Exact Sciences's latest financial reports the company's current earnings are ยฃ3.08 Billion. In 2024 the company made an earning of -ยฃ0.75 Billion a decrease over its 2023 earnings that were of -ยฃ0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ0.78 Billion3.81%
2024 -ยฃ0.75 Billion435.05%
2023 -ยฃ0.14 Billion-69.18%
2022 -ยฃ0.45 Billion-25.77%
2021 -ยฃ0.61 Billion1.68%
2020 -ยฃ0.6 Billion271.17%
2019 -ยฃ0.17 Billion58.99%
2018 -ยฃ0.11 Billion20.89%
2017 -ยฃ83.58 Million-30.95%
2016 -ยฃ0.13 Billion5.09%
2015 -ยฃ0.12 Billion57.24%
2014 -ยฃ73.26 Million116.53%
2013 -ยฃ33.83 Million
2011 -ยฃ21.07 Million143.73%
2010 -ยฃ8.65 Million27.85%
2009 -ยฃ6.76 Million0.27%
2008 -ยฃ6.75 Million-20.95%
2007 -ยฃ8.53 Million-13.53%
2006 -ยฃ9.87 Million-10.07%
2005 -ยฃ10.97 Million-21.81%
2004 -ยฃ14.03 Million-33.44%
2003 -ยฃ21.08 Million-6.51%
2002 -ยฃ22.54 Million17.95%
2001 -ยฃ19.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
ยฃ6.64 B-1,038.16%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
ยฃ18.08 M-102.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
ยฃ48.14 M-106.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-ยฃ0.31 Billion-56.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-ยฃ25.56 Million-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA